The bill is intended to clarify the employment status of individuals participating in clinical trials, thereby alleviating potential legal and financial burdens for research entities. By defining participants in this manner, SB387 aims to encourage more individuals to engage in clinical research, which could expedite the development of new medical treatments and innovations. This change in classification could also influence how remuneration is perceived in research contexts, potentially increasing participation rates in clinical studies.
Summary
Senate Bill 387 seeks to amend existing laws regarding the classification of individuals who participate in clinical research trials. The bill explicitly states that such participants are not considered employees of the entity conducting the trial for the purposes of the minimum wage law and worker's compensation law. It indicates that remuneration or compensation received by these participants will not classify them as employees, thus exempting their payments from minimum wage considerations and worker's compensation liabilities.
Contention
While supporters may view SB387 as a necessary update to encourage clinical research, opponents might raise concerns about the potential exploitation of trial participants. Critics could argue that classifying these individuals as non-employees may lead to insufficient protections related to fair compensation, safety standards, and rights of participants under worker protection laws. Additionally, implications for unemployment insurance are notable, as participants not being eligible for such benefits may create disparities in welfare support during and after their participation in research studies.